Patents by Inventor Desiree Van Der Heijde

Desiree Van Der Heijde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES AND COMPOSITIONS FOR TREATMENT OF ANKLOSING SPONDYLITIS
    Publication number: 20190040124
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 28, 2018
    Publication date: February 7, 2019
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Uses and Compositions for Treatment of Ankylosing Spondylitis
    Publication number: 20160251424
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: March 7, 2016
    Publication date: September 1, 2016
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Uses and compositions for treatment of ankylosing spondylitis
    Publication number: 20090123378
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 4, 2008
    Publication date: May 14, 2009
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych